Search Results

March 12, 2019 | New York Law Journal

Federal Circuit May Decide Whether Successful IPR Petitioners Are Estopped from Using Winning Prior Art Combinations in Parallel District Court Litigation

Intellectual Property Litigation columnists Lewis R. Clayton and Eric Alan Stone discuss 'BTG Int'l Ltd. v. Amneal Pharm.', in which the Federal Circuit may decide whether §315(e)(2) acts to bar a successful IPR petitioner from asserting in district court the arguments on which it prevailed before the PTAB.

1 minute read

March 11, 2019 | Delaware Business Court Insider

Takeda Unit Asks Judge to Wipe Out $155M Infringement Verdict Over Hemophilia Drug

In a court filing Friday, Baxalta Inc. argued that Bayer's patent was invalid and that the German-based pharmaceutical firm had presented no evidence to support the jury's damages award.

1 minute read

March 8, 2019 | The Legal Intelligencer

The Attraction to E-Cigarettes Is Actually One of Its Biggest Risks

What is most attractive about e-cigarettes like the JUUL is that they come in a variety of flavors and are widely accessible, drawing in JUUL's most common user, the young adult.

1 minute read

February 28, 2019 | Corporate Counsel

Tesla, CBS and United See New General Counsel: February 2019 In-House Moves

A roundup of major in-house moves occurring in February.

1 minute read

February 22, 2019 | The Legal Intelligencer

Allentown Pharma Company Agrees to Pay $4M Penalty for Allegedly Dodging FDA Fees

Lehigh Valley Technologies, an Allentown-based pharmaceutical company, has entered into a $4 million agreement with the government to settle claims that it schemed to avoid paying certain FDA fees, Philadelphia-area U.S. Attorney William McSwain announced Friday.

1 minute read

State of Delaware v. Purdue Pharma L.P.

Publication Date: 2019-02-20
Practice Area: Consumer Protection
Industry: Pharmaceuticals | Retail
Court: Delaware Superior Court
Judge: Judge Johnston
Attorneys: For plaintiff: Ryan P. Newell, Shaun Michael Kelly and Kyle Evans Gay of Connolly Gallagher, LLP; Richard W. Fields of Fields PLLC; Scott W. Gilbert, Richard Shore, Mark A. Packman, Jenna A. Hudson, Michael B. Rush, Monique T. Abrishami and Richard J. Leveridge, Gilbert LLP, Washington, DC; Kathleen Jen-nings, attorney general, and Michael Vild and Michelle Whalen, Delaware Dep't of Justice for the state.
for defendant: Brian D. Tome and Kelly E. Rowe, Reilly, McDevitt & Henrich, PC, Wilmington, DE; Mark S. Cheffo, Hay-den A. Coleman, Debra D. O'Gorman and Judy L. Leone, Dechert LLP, Philadelphia, PA for defendant Purdue Pharma. Michael P. Kelly, Steven P. Wood, Daniel J. Brown and Hayley J. Reese, McCarter & English, Wilmington, DE; John A. Freedman and Sean O. Morris, Arnold & Porter Kay Scholer LLP, Los Angeles, CA for defendant Endo Pharmaceuticals. Kevin B. Collins, Katherine B. Shaffer and Neil K. Roman, Covington & Burling, New York, NY; A. Thompson Bayliss, Michael A. Barlow, Sarah E. Delia, David A. Seal and Daniel J. McBride, Abrams & Bayliss, Wilmington, DE for defendant McKesson Corp. David A. Felice, Bailey & Glasser LLP, Wilmington, DE, Steven Pyser, Ashley W. Hardin and Joshua D. Tully, Williams & Connolly, Washington, DC for defendant Cardinal Health. Jennifer C. Wasson, Jesse L. Noa and Carla M. Jones, Potter, Anderson & Corroon LLP, Wilmington, DE; Louis W. Schack, Shan-non E. McClure and Neil A. Hlawatsch of Reed Smith LLP for defendant AmerisourceBergen. Jami B. Nimeroff, Brown, Garry, Nimeroff, Wilmington, DE; James W. Matthews, Katy E. Koski, Jaclyn V. Piltch and Redi Kasollja, Foley & Lardner, Boston, MA for defendant Anda Pharmaceuticals. Thomas E. Han-son and Oni N. Harton, Barnes & Thornburg LLP, Wilmington, DE and Indianapolis, IN for defendant H.D. Smith LLC. Daniel B. Rath, Rebecca L. Butcher and Jennifer L. Cree, Landis, Rath & Cobb LLP, Wilmington, DE; Eric R. Delinsky, Alexandra W. Miller and R. Miles Clark, Zuckerman Spaeder LLP, Washington, DC for defendant CVS Health Corp. Beth Moskow-Schnoll, William Burton and Elizabeth A. Sloan, Ballard Spahr LLP, Wilmington, DE; Kaspar J. Stoffelmayr, Katherine M. Swift and Alex J. Har-ris, Bartlit, Beck, Herman, Palenchar & Scott LLP, Chicago, IL and Denver, CO for defendant Walgreens Boots Alliance, Inc.
Case Number: D68469

The state adequately alleged claims against manufacturers and distributors of opioids, but the court dismissed public nuisance, civil conspiracy and unjust enrichment claims.

Nguyen v. New Link Genetics Corp.

Publication Date: 2019-02-20
Practice Area: Securities Litigation
Industry: Pharmaceuticals
Court: U.S. District Court for the Southern District of New York, U.S. - SDNY
Judge: District Judge William Pauley
Attorneys: For plaintiff:
for defendant:
Case Number: 16 cv 3545

Securities Fraud Suit Over Cancer Drug Dismissed; Falsity, Loss Causation Not Pleaded

February 13, 2019 | Law.com

Inside Track: A GC for Robots? | Into the Breach - GDPR Edition

A consensus is forming that AI needs legal supervision. Also, data breaches reported in Europe suggest a looming wave of GDPR enforcement and we suss out the difference between the roles of GC and chief legal officer.

1 minute read

February 11, 2019 | Delaware Business Court Insider

AbbVie Ordered to Quickly Produce Docs in Humira Infringement Suit

The Feb. 8 ruling, from U.S. Magistrate Judge Richard A. Lloret, came in response to Boehringer's second set of production requests pertaining to its "unclean hands" defense in Abbvie's infringement suit, which accuses the German drugmaker of trying to illegally capitalize on Humira's clinical success.

1 minute read

February 8, 2019 | New Jersey Law Journal

Bayer Wins $155M Patent Infringement Verdict Over Hemophilia Treatment

A federal jury has ordered a unit of Takeda Pharmaceutical Co. to pay Bayer HealthCare LLC $155 million in damages for infringing a patent related to Bayer's hemophilia treatment.

1 minute read